SCHEDULE 13G/A: RTW Investments and Dr. Roderick Wong Maintain Significant 9.99% Stake in Establishment Labs Holdings Inc.
Beneficial Ownership Disclosure
RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a continued beneficial ownership of 9.99% in Establishment Labs Holdings Inc., as detailed in their latest Schedule 13G/A filing.
Summary
- RTW Investments, LP and Roderick Wong, M.D. collectively beneficially own 2,822,216 common shares of Establishment Labs Holdings Inc.
- This ownership represents 9.99% of the company's common shares outstanding.
- The calculation of beneficial ownership includes warrants to purchase 252,529 shares.
- The percentage is based on 27,997,883 shares outstanding as of November 11, 2024, as reported in the company's Form 10-Q.
- The filing is an Amendment No. 6 to a Schedule 13G, indicating an update to a previously reported stake.
- RTW Investments, LP is a Delaware limited partnership and an investment adviser, while Dr. Wong is a U.S. citizen and the Managing Partner and Chief Investment Officer of RTW Investments.
Sentiment
Score: 7
Explanation: The filing indicates a continued significant stake by RTW Investments, LP and Roderick Wong, M.D., in Establishment Labs Holdings Inc., suggesting ongoing institutional confidence in the company.
Positives
- The continued significant stake of 9.99% by RTW Investments, LP and Roderick Wong, M.D., a specialized investment firm, suggests ongoing institutional confidence in Establishment Labs Holdings Inc.
- The inclusion of warrants in the beneficial ownership calculation indicates a potential long-term investment perspective from the reporting persons.
Industry Context
This filing is a routine disclosure of a significant ownership stake by an institutional investor, RTW Investments, LP, in Establishment Labs Holdings Inc. It reflects an ongoing investment position rather than a new strategic move or a change in industry trends.
Stakeholder Impact
- Shareholders may view the continued significant stake by a specialized investment firm as a positive signal of confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 2024-11-11 | Date as of which 27,997,883 shares outstanding were reported in the Company's Quarterly Report on Form 10-Q. |
| 2024-12-31 | Date of event which required the filing of this statement. |
| 2025-02-14 | Date of filing of the Schedule 13G/A statement. |
Keywords
Establishment Labs Holdings Inc., RTW Investments, Roderick Wong, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Shares, SEC Filing, Investment Adviser, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.